Quovadis Janeene Epps

Northeast Florida Pharmacy Practice Center Building 4800. Suite 200
By appointment

PHA 4036 301 Population Based Care I Th. __ 1:00 p.m. - 2:40 p.m.
PHA 4036 3C1 Population Based Care I Th.__ 12:00 p.m. - 1:40 p.m.

---

---

Dr. Quovadis Epps is an Associate Professor of Pharmacy Practice at Florida Agricultural and Mechanical University (FAMU) College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH). Dr. Epps serves as the Residency Program Director for the Walgreens Pharmacy and FAMU CoPPS, IPH PGY1 Community Residency Program. With more than 15 years of exclusive health-system pharmacy experience prior to joining the FAMU faculty, she serves as a General Medicine Preceptor at the Northeast Pharmacy Practice Center where she assists learners in transiting information learned in didactic courses to clinical practice in the hospital setting. Dr. Epps has helped to development and implement several residency programs for the University and helped train the residents. She currently is the course coordinator for the Population Based Care I Course which focuses on population health management and those factors which impacts ones health.

---

---

• Anticoagulation
  
  
• Infectious Disease
  
  
• Population Health
  
  
• Post Graduate Training

---

---

---

---

• Assistant Professor, Pharmacy Practice, Residency Program Director - April 2015 - Present
  Florida A&M University, Tallahassee, FL
• Clinical Pharmacist – January 2008 – April 2015
  St. Vincent’s Medical Center Southside, Jacksonville, FL
• Therapeutic Drug Specialist, Residency Coordinator - September 2005- January 2018
  Baptist Medical Center Jacksonville, Jacksonville, FL
• Staff Pharmacist - June 2000 – June 2023
  Baptist Medical Center Jacksonville, Jacksonville, FL. 

---

---

Publications

• Epps Quovadis J, Epps Kevin L, Young David C, Zobell Jeffery T. State of the art in cystic
  fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis
  pulmonary exacerbations: III. Executive summary. Pediatr Pulmonol. 2021 Jul;56(7):1825-
  1837. Doi: 10.1002/ppul.25353. Epub 2021 Mar 15. PMID: 33656280.
  
  
• Epps Quovadis J, Epps Kevin L, Zobell Jeffery T, Young David C. Optimization of
  antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for
  allergic bronchopulmonary aspergillosis. Pediatr Pulmonol. 2020 Dec;55(12):3541-3572. Doi:
  10.1002/ppul.25080. Epub 2020 Sep 29. PMID: 32946194.
  
  
• Epps Quovadis J, Epps Kevin L, Young David C, Zobell Jeffery T. State of the art in cystic
  fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics. Pediatr Pulmonol. 2020 Jan;55(1):33-57. Doi: 10.1002/ppul.24537. Epub 2019 Oct 14. PMID: 31609097.
  
  
• Barr Drakeria, Epps Quovadis J. Direct oral anticoagulants: a review of common medication errors. J Thromb Thrombolysis. 2019 Jan;47(1):146-154. Doi: 10.1007/s11239-018-1752-9. PMID: 30298305.CoPPS, IPH Pharmacy Resident Collaboration.
  
  
• Epps Kevin L, Epps Quovadis J, Mourad H, Reger EB, Libertin CR. Is Annual Cumulative
  Susceptibility Test Data Enough to Guide Empirical Therapy for Pseudomonas aeruginosa
  Pneumonia? Am J Clin Microbiol Antimicrob. 2018; 1(6): 1026.

Letters

• Epps Quovadis J, Epps Kevin L, Zobell Jeffery T. Optimization of antipseudomonal antibiotics
  for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update.
  Pediatr Pulmonol. 2021 Jun;56(6):1784-1788. Doi: 10.1002/ppul.25282. Epub 2021 Feb 1.
  PMID: 33524241.

---

---

• Teacher of the Year 2020-2021
  
• Decanal Commendation for Pharmacists Interventions 2019-2020
  
• Teacher of the Year 2017-2018

---

---

• PHA 4036 Population Based Care I
  
• PHA 5694 APPE General Medicine
  
• PHA 5917L Clinical Seminar and Research Methods Lab I
  
• PHA 5918L Clinical Seminar and Research Methods Lab II
  
• PHA 5919L Clinical Seminar and Research Methods Lab III